Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT01648556Not ApplicableCompleted

Research of Predictive Factors to Immune Thrombopenic Purpura

Role: collaborator

NCT03272724Recruiting

French National Observatory on Infective Endocarditis

Role: collaborator

NCT06893757Not Yet Recruiting

Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)

Role: collaborator

NCT02846064Not ApplicableRecruiting

Development of Ovarian Tissue Autograft in Order to Restore Ovarian Function

Role: collaborator

NCT03954197Not ApplicableUnknown

Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients

Role: lead

NCT01460524Completed

Nebulized Hypertonic Saline for Bronchiolitis

Role: collaborator

NCT01694524Completed

Nervous System Infections Among Patients With Febrile Seizure

Role: collaborator

NCT00378729Phase 4Unknown

Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS)

Role: collaborator

All 8 trials loaded